Stay updated on Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.

Latest updates to the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page
- Check6 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 was added and the previous Revision: v3.4.1 entry was removed. The updates appear to be administrative page maintenance and do not alter study content or results.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center’s operating status, and updated the site release to v3.4.1 (replacing 3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check48 days agoChange DetectedShow glossary option added and metadata labels updated to include 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and Revision: v3.4.0. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and Revision: v3.3.4 were removed.SummaryDifference0.2%

- Check62 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no visible changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now includes a centralized 'Locations' section listing US sites by state (California, Florida, Georgia, Indiana, Michigan, Ohio, Tennessee, Texas, Virginia) and removes the separate 'X Locations' sections; it also shows the revision tag Revision: v3.3.3.SummaryDifference0.9%

Stay in the know with updates to Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bermekimab Safety & Efficacy in Atopic Dermatitis Clinical Trial page.